Latest News on PAHC

Financial News Based On Company


Advertisement
Advertisement

Phibro Animal Health Reports Q1 FY2027 Net Sales Increase to $386.8 Million

https://kalkinemedia.com/us/news/announcements/phibro-animal-health-reports-q1-fy2027-net-sales-increase-to-3868-million
Phibro Animal Health Corporation reported its first-quarter financial results for FY2027, ending September 30, 2026, with net sales increasing to $386.8 million, up from $363.9 million in the prior-year quarter. Net income also rose to $29.5 million, resulting in diluted EPS of $0.72. The company filed its Form 10-Q with the SEC on November 4, 2026, detailing these financial improvements and an increase in total stockholders' equity.

Phibro Animal Health Declares $0.12 Quarterly Dividend

https://www.tradingview.com/news/tradingview:4290e8e29ec25:0-phibro-animal-health-declares-0-12-quarterly-dividend/
Phibro Animal Health (PAHC) has declared a quarterly cash dividend of $0.12 per share for both its Class A and Class B common stock. The payment is scheduled for December 16, 2026, with stockholders of record on November 25, 2026, being eligible. This declaration was based on an SEC filing from November 3, 2026.

Shareholders will get 12 cents per share from Phibro Animal Health on Dec. 16

https://www.stocktitan.net/news/PAHC/phibro-animal-health-corporation-declares-quarterly-oxdd7vq10o92.html
Phibro Animal Health Corporation (Nasdaq: PAHC) has declared a quarterly cash dividend of $0.12 per share for both its Class A and Class B common stock. This dividend is payable on December 16, 2026, to shareholders of record as of November 25, 2026. The company is a global diversified animal health and nutrition provider.

Form DEF 14A Phibro Animal Health Corporation For: 2 November By Investing.com

https://in.investing.com/news/stock-market-news/form-def-14a-phibro-animal-health-corporation-for-2-november-93CH-5670660
This article from Investing.com announces that Phibro Animal Health Corporation (PAHC) filed its Form DEF 14A for November 2. The filing is related to the company's stock market activities.

Form DEF 14A Phibro Animal Health Corporation For: 2 November By Investing.com

https://ca.investing.com/news/stock-market-news/form-def-14a-phibro-animal-health-corporation-for-2-november-93CH-4920919
This article announces that Phibro Animal Health Corporation (PAHC) filed a DEF 14A form for November 2nd. The filing is available through Investing.com, indicating routine corporate disclosure related to a proxy statement. The stock symbol PAHC is noted with a 3.19% increase.
Advertisement

Phibro Animal Health Corporatio (PAHC) Stock forecasts

https://sg.finance.yahoo.com/research/reports/ARGUS_4698_QuantitativeReport_1792540800000/
Argus raised its target price for Phibro Animal Health Corp (PAHC) stock to $37.00. The company operates as a diversified animal health and mineral nutrition company, developing, manufacturing, and marketing products for various food animals. As of the report date, PAHC's current price is $39.81.

Three reporting persons share voting power over 822,639 Phibro Animal Health (PAHC) shares.

https://www.stocktitan.net/sec-filings/PAHC/schedule-13g-a-phibro-animal-health-corp-amended-passive-investment-d-c3ee7d039de8.html
Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander have jointly reported shared voting and dispositive power over 822,639 Class A shares of Phibro Animal Health Corporation (PAHC), representing 3.9% of the class. This disclosure was made via a SCHEDULE 13G/A filing with the SEC. The shares are held by entities under the investment discretion of Millennium Management LLC and/or other related investment managers.

Phibro Animal Health Corporatio (PAHC) Stock Forecasts

https://ca.finance.yahoo.com/research/reports/ARGUS_4698_QuantitativeReport_1790726400000
Argus has raised its target price for Phibro Animal Health Corp (PAHC) to $34.00, despite the current price being $38.80. The company operates as a diversified animal health and mineral nutrition provider, focusing on products for various food animals. This report suggests a specific analyst outlook on PAHC's stock performance.

Phibro Animal Health CFO David Glenn Granted 3,482 Shares, Increasing Holdings to 54,959

https://kalkinemedia.com/us/news/announcements/phibro-animal-health-cfo-david-glenn-granted-3482-shares-increasing-holdings-to-54959
Phibro Animal Health CFO David Glenn was granted 3,482 shares on August 6, 2026, which increased his total holdings in the company to 54,959 shares. This award represents approximately 6.3% of his total share position after the transaction. The transaction was classified under code A, indicating it was an award or grant from PHIBRO ANIMAL HEALTH CORP (NASDAQ:PAHC).

Phibro Animal Health Corp Grants COO Miller Larry Lee 3,726 Shares, Increasing His Stake to 38,275

https://kalkinemedia.com/us/news/announcements/phibro-animal-health-corp-grants-coo-miller-larry-lee-3726-shares-increasing-his-stake-to-38275
Phibro Animal Health Corp awarded 3,726 shares to its COO, Miller Larry Lee, on August 6, 2026. This grant increased his total holdings in the company to 38,275 shares, representing approximately 9.7% of his new share position. The transaction was classified under code A and was disclosed via a Form 4/A filing.
Advertisement

Phibro Animal Health (PAHC) updates CFO’s 3,482-unit stock grant

https://www.stocktitan.net/sec-filings/PAHC/form-4-a-phibro-animal-health-corp-amended-insider-trading-activity-b6eda84555d0.html
Phibro Animal Health (PAHC) has filed an amended Form 4 to correct an understated RSU grant for its CFO, David Glenn. The amended filing shows Glenn received 3,482 restricted stock units (RSUs) on August 6, 2026, which will vest in three equal annual installments. After this grant, Glenn directly holds 54,959 shares of Class A Common Stock.

COO stock award takes Phibro Animal Health (PAHC) stake to 38,275 units

https://www.stocktitan.net/sec-filings/PAHC/form-4-a-phibro-animal-health-corp-amended-insider-trading-activity-676d7ce9f5f8.html
Phibro Animal Health Corp. (PAHC) Chief Operating Officer, Larry Lee Miller, received a corrected grant of 3,726 restricted stock units (RSUs), bringing his total direct holdings to 38,275 shares/RSUs. This amendment corrects an earlier filing that understated the number of RSUs due to a calculation error. The RSUs vest over three years, contingent on his continued employment.

Big Phibro Animal Health (PAHC) investor lines up stock sale plan

https://www.stocktitan.net/sec-filings/PAHC/144-phibro-animal-health-corp-sec-filing-48ddca20f8e7.html
BFI Co. LLC, a significant shareholder in Phibro Animal Health (PAHC), has filed a Form 144 indicating an intention to sell up to 350,000 shares of Class A Common Stock through Goldman Sachs & Co. LLC. This proposed sale, valued at approximately $12.355 million, is scheduled to commence around September 16, 2026, and is part of a pre-planned selling arrangement to comply with Rule 10b5-1(c). The shares were originally acquired in a private placement in 2014.

Phibro Animal Health Submits Annual 10-K Report for Fiscal Year Ending June 30, 2026

https://kalkinemedia.com/us/news/announcements/phibro-animal-health-submits-annual-10-k-report-for-fiscal-year-ending-june-30-2026
Phibro Animal Health Corporation (NASDAQ: PAHC) filed its Annual Report on Form 10-K for the fiscal year ended June 30, 2026, with the SEC on August 26, 2026. The report details key financial information including outstanding shares of Class A and Class B common stock, their market value held by non-affiliates, and outlines various risk factors that could impact the company's future performance. The company is classified as a large accelerated filer, and its proxy statement will be incorporated by reference within 120 days post fiscal year-end.

Phibro Animal Health to report Q4 FY26 results on August 26

https://scanx.trade/stock-market-news/companies/phibro-animal-health-report-q4-fy26-results-august-26/48717464
Phibro Animal Health Corporation (NASDAQ: PAHC) is scheduled to announce its fourth quarter and fiscal year 2026 financial results after market close on Wednesday, August 26, 2026. Management will host a conference call and webcast on Thursday, August 27, 2026, at 9:00 am ET to discuss these results. Investors can access the live event via the company's investor relations website or by phone using Conference ID 3927884.
Advertisement

Phibro Animal Health (PAHC) awards 3,522 RSUs to Chief Operating Officer

https://www.stocktitan.net/sec-filings/PAHC/form-4-phibro-animal-health-corp-insider-trading-activity-e3644a3b0434.html
Phibro Animal Health Corp (PAHC) has granted 3,522 restricted stock units (RSUs) to its Chief Operating Officer, Larry Lee Miller. These RSUs, representing Class A Common Stock, will vest in three equal installments over three years, contingent on his continued employment. Following this grant, Miller directly holds 38,071 shares of Class A Common Stock, including the newly awarded RSUs.

Phibro Animal Health CFO David Glenn Awarded 3,334 RSUs on August 6, 2026

https://kalkinemedia.com/us/news/announcements/phibro-animal-health-cfo-david-glenn-awarded-3334-rsus-on-august-6-2026
David Glenn, CFO of Phibro Animal Health Corp (NASDAQ: PAHC), was awarded 3,334 restricted stock units (RSUs) of Class A Common Stock on August 6, 2026. The filing for this acquisition was made on August 10, 2026, with the RSUs valued at $0.

Phibro Animal Health (PAHC) grants 12,103 RSUs to Executive Chairman Bendheim

https://www.stocktitan.net/sec-filings/PAHC/form-4-phibro-animal-health-corp-insider-trading-activity-6680d66fb3dc.html
Phibro Animal Health Corp. (PAHC) Executive Chairman and 10% owner Jack Bendheim was granted 12,103 restricted stock units (RSUs). These RSUs, each representing one share of Class A Common Stock, will vest in equal installments over the first three anniversaries of August 1, 2026, contingent on his continued employment. Following this grant, Bendheim directly holds 26,640 Class A shares and has shared voting and investment power over an additional 56,152 Class A shares held by BFI Co., LLC.

Phibro Animal Health (NASDAQ: PAHC) awards 1,503 RSUs to VP Finance

https://www.stocktitan.net/sec-filings/PAHC/form-4-phibro-animal-health-corp-insider-trading-activity-f8216753809d.html
Phibro Animal Health Corp (NASDAQ: PAHC) has awarded its VP Finance and Treasurer, Patrick Rodriguez, 1,503 restricted stock units (RSUs) representing Class A Common Stock. These RSUs will vest in substantially equal installments over the first three anniversaries of August 1, 2026, contingent on his continued employment. Following this award, Rodriguez directly holds 1,503 shares of Class A Common Stock, with the transaction valued at $0.00 per share, consistent with a compensation award.

Phibro Animal Health (PAHC) grants 11,699 RSUs to President and CEO

https://www.stocktitan.net/sec-filings/PAHC/form-4-phibro-animal-health-corp-insider-trading-activity-8aa7a27c4329.html
Phibro Animal Health (PAHC) reported that its President and CEO, Daniel M. Bendheim, was granted 11,699 restricted stock units (RSUs). These RSUs represent a contingent right to receive one share of Class A Common Stock each, vesting in three equal annual installments beginning August 1, 2026, contingent on his continued employment. Following this grant, Bendheim directly holds 15,177 shares of Class A Common Stock, including the newly awarded RSUs.
Advertisement

Phibro Animal Health (PAHC) awards 1,547 RSUs to SVP of Human Resources

https://www.stocktitan.net/sec-filings/PAHC/form-4-phibro-animal-health-corp-insider-trading-activity-bfb7d01c9e18.html
Phibro Animal Health (PAHC) awarded 1,547 restricted stock units (RSUs) to Lisa Ann Escudero, SVP of Human Resources, on August 6, 2026. These RSUs will vest in three equal installments on the first three anniversaries of August 1, 2026, contingent on her continued employment. Following this grant, Escudero directly holds 3,434 shares or share-equivalent RSUs of Class A Common Stock.

Phibro Animal Health (NASDAQ: PAHC) awards 2,478 RSUs to senior legal officer

https://www.stocktitan.net/sec-filings/PAHC/form-4-phibro-animal-health-corp-insider-trading-activity-8cfc27e1aa41.html
Phibro Animal Health Corp (NASDAQ: PAHC) has awarded 2,478 Restricted Stock Units (RSUs) to Judith Weinstein, its Senior Vice President and General Counsel. This grant increases her direct holdings to 5,453 shares. The RSUs will vest in substantially equal installments over three years, beginning August 1, 2026, contingent upon her continued employment.

Phibro Animal Health (NASDAQ: PAHC) CFO receives 3,334-share restricted stock grant

https://www.stocktitan.net/sec-filings/PAHC/form-4-phibro-animal-health-corp-insider-trading-activity-04628b76b022.html
Phibro Animal Health (NASDAQ: PAHC) CFO David Glenn was granted 3,334 restricted stock units (RSUs). These RSUs, which represent Class A Common Stock, were awarded at a price of $0.00 per share and will vest in three equal annual installments starting August 1, 2026, contingent on his continued employment. Following this grant, Glenn's direct holdings in Class A Common Stock total 54,811 shares.

Phibro Animal Health (PAHC) grants 2,716 RSUs to director Jonathan Bendheim

https://www.stocktitan.net/sec-filings/PAHC/form-4-phibro-animal-health-corp-insider-trading-activity-5cd2f5175728.html
Phibro Animal Health (PAHC) director Jonathan Bendheim was granted 2,716 restricted stock units (RSUs) on August 6, 2026. These RSUs represent a contingent right to receive one share of Class A Common Stock each, and they will vest in substantially equal installments on the first three anniversaries of August 1, 2026, provided Bendheim remains employed. Following this transaction, Bendheim directly holds 5,984 shares of Class A Common Stock.

Phibro Animal Health COO Larry Lee Miller Awarded 3,522 RSUs in August 2026

https://kalkinemedia.com/us/news/announcements/phibro-animal-health-coo-larry-lee-miller-awarded-3522-rsus-in-august-2026
Larry Lee Miller, COO of Phibro Animal Health Corp (NASDAQ:PAHC), was awarded 3,522 restricted stock units (RSUs) on August 6, 2026. These RSUs, granted at no cost, will vest in equal portions over three years, contingent on his continued employment. Following this grant, Miller directly owns 38,071 shares of Class A Common Stock.
Advertisement

CEO of Phibro Animal Health (NASDAQ: PAHC) sells 486 shares for taxes

https://www.stocktitan.net/sec-filings/PAHC/form-4-phibro-animal-health-corp-insider-trading-activity-11621424568b.html
Daniel M Bendheim, President and CEO of Phibro Animal Health (PAHC), reported selling 486 shares of Class A Common Stock for $36.599 per share on August 4, 2026. This transaction was a broker-assisted cashless sale to cover tax withholding obligations associated with the vesting of restricted stock units. After the sale, Bendheim directly holds 3,478 shares.

Phibro Animal Health (NASDAQ: PAHC) COO sells 635 shares for tax withholding

https://www.stocktitan.net/sec-filings/PAHC/form-4-phibro-animal-health-corp-insider-trading-activity-6fff058ff529.html
Phibro Animal Health's Chief Operating Officer, Larry Lee Miller, sold 635 shares of Class A Common Stock on August 4, 2026, at a price of $36.599 per share. This transaction was a broker-assisted cashless exercise to cover tax withholding obligations associated with the vesting of restricted stock units. Following the sale, Miller directly holds 34,549 shares of the company.

Phibro Animal Health (NASDAQ: PAHC) GC sells 472 shares for taxes

https://www.stocktitan.net/sec-filings/PAHC/form-4-phibro-animal-health-corp-insider-trading-activity-699bcfe47362.html
Phibro Animal Health's General Counsel, Judith Weinstein, sold 472 shares of Class A Common Stock on August 4, 2026, at $36.599 per share. This transaction was a broker-assisted cashless exercise to cover tax withholding obligations upon the vesting of restricted stock units. Following this sale, Weinstein directly holds 2,975 shares of Class A Common Stock.

Phibro Animal Health (PAHC) chair disposes 2,303 shares to cover tax withholding

https://www.stocktitan.net/sec-filings/PAHC/form-4-phibro-animal-health-corp-insider-trading-activity-13bbef8245a9.html
Jack Bendheim, Executive Chairman and 10% owner of Phibro Animal Health (PAHC), disposed of 2,303 shares of Class A Common Stock on August 4, 2026. This transaction was conducted through a broker-assisted cashless exercise program to cover tax withholding obligations upon the vesting and settlement of restricted stock units. Following this, Bendheim directly holds 14,537 Class A shares and indirectly holds 56,152 shares through BFI Co., LLC.

Phibro Animal Health (PAHC) CFO sells 840 shares to cover taxes

https://www.stocktitan.net/sec-filings/PAHC/form-4-phibro-animal-health-corp-insider-trading-activity-fbf684325808.html
Phibro Animal Health's CFO, David Glenn, disposed of 840 shares of Class A Common Stock on August 4, 2026, at an average price of $36.599 per share. This transaction was a broker-assisted cashless exercise performed to satisfy tax withholding obligations related to the vesting of restricted stock units. Following this disposition, Glenn directly owns 51,477 shares of PAHC.
Advertisement

FMR LLC discloses 15% ownership of Phibro Animal Health (PAHC) Class A shares

https://www.stocktitan.net/sec-filings/PAHC/schedule-13g-a-phibro-animal-health-corp-amended-passive-investment-d-9accd91ca213.html
FMR LLC and Abigail P. Johnson have reported a 15.0% beneficial ownership stake in Phibro Animal Health Corp's Class A common stock, totaling 3,160,280.92 shares as of June 30, 2026. FMR LLC holds sole voting power over 3,159,853 shares and sole dispositive power over all reported shares, while Abigail P. Johnson has sole dispositive power over the same amount but no voting power. This disclosure, filed as an amended Schedule 13G/A, indicates that other individuals may have dividend or sale proceeds rights but none exceed 5% ownership.

Phibro Animal Health (PAHC) HR chief sells 265 shares to cover tax withholding

https://www.stocktitan.net/sec-filings/PAHC/form-4-phibro-animal-health-corp-insider-trading-activity-e042ae2654a7.html
Lisa Ann Escudero, SVP of Human Resources at Phibro Animal Health (PAHC), sold 265 shares of Class A Common Stock on August 4, 2026, to cover tax withholding obligations associated with the vesting of restricted stock units. The transaction was a broker-assisted cashless sale at $36.599 per share. After this sale, Escudero directly holds 1,887 shares of PAHC.

PHIBRO ANIMAL HEALTH CORP SEC Filing (Aug 4, 2026)

https://www.stocktitan.net/sec-filings/PAHC/144-phibro-animal-health-corp-sec-filing-ce2023ec6d23.html
This article details a Form 144 SEC filing by Phibro Animal Health Corp (PAHC) on August 4, 2026. The filing indicates a proposed sale of 486 shares of Class A common stock by an individual, acquired through restricted stock vesting. The aggregate market value of the shares to be sold is $17,787.31, with the sale expected on August 4, 2026, on NASDAQ.

Millennium group (NASDAQ: PAHC) discloses 1.06M-share Phibro Animal Health position

https://www.stocktitan.net/sec-filings/PAHC/schedule-13g-phibro-animal-health-corp-passive-investment-disclosure--81773857d854.html
Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander have reported beneficial ownership of 1,064,608 shares of Phibro Animal Health Corporation (PAHC) Class A common stock, which represents 5.1% of the class. They indicate shared voting and dispositive power over these shares, with no sole voting or dispositive power. The securities are held by entities managed by Millennium Management LLC and its affiliates, with Mr. Englander as a key figure in control, emphasizing that this report does not admit beneficial ownership beyond the filing requirements.

Phibro Animal Health declares $0.12 quarterly dividend payable Sept. 23

https://www.tradingview.com/news/tradingview:4cadd8d7a1aab:0-phibro-animal-health-declares-0-12-quarterly-dividend-payable-sept-23/
Phibro Animal Health (PAHC) has declared a quarterly cash dividend of $0.12 per share for both Class A and Class B common stock. The dividend is payable on September 23, 2026, to shareholders of record as of September 2, 2026. This announcement was filed as an Exhibit 99.1 to the company's Form 8-K on July 28, 2026.
Advertisement

Phibro shareholders set to receive $0.12 dividend Sept. 23

https://www.stocktitan.net/news/PAHC/phibro-animal-health-corporation-declares-quarterly-6pu0kkkgkvh8.html
Phibro Animal Health Corporation announced a quarterly cash dividend of $0.12 per share for its Class A and Class B common stock. The dividend is payable on September 23, 2026, to stockholders of record as of September 2, 2026. Phibro Animal Health is a global animal health and nutrition company.

Las ETF que invierten en acciones de Phibro Animal Health Corporation Class A

https://es.tradingview.com/symbols/FWB-PB8/etfs/
This article lists various ETFs that invest in Phibro Animal Health Corporation Class A stock, primarily focusing on small-cap and healthcare-related funds. It provides detailed financial data for each ETF, including market value, weight, issuer, management style, expense ratio, and total returns. The information aims to assist investors interested in the stock by showcasing diversified investment opportunities with potentially lower risk.

Is Phibro Animal Health (PAHC) Undervalued After Its Russell Index Removal?

https://www.sahmcapital.com/news/content/is-phibro-animal-health-pahc-undervalued-after-its-russell-index-removal-2026-07-02
Phibro Animal Health (PAHC) has been removed from several Russell indices, impacting potential ownership and liquidity. Despite a recent stock performance dip, the company is considered 29.6% undervalued by analysts, with a fair value target of $45.60 compared to its current $32.10. However, its core business faces challenges from consumer preferences and regulatory scrutiny regarding antibiotic use, which could affect future margins and earnings.

Phibro (NASDAQ: PAHC) CEO receives 300,000 performance units award

https://www.stocktitan.net/sec-filings/PAHC/form-4-phibro-animal-health-corp-insider-trading-activity-e9c63b7a7df9.html
Phibro Animal Health Corporation's President and CEO, Daniel M. Bendheim, has been granted 300,000 Performance Stock Units (PSUs). These PSUs represent a contingent right to receive Class A Common Stock, with vesting scheduled for June 30, 2031, subject to the achievement of specified stock price performance and Bendheim’s continued employment. This insider transaction was reported in a Form 4 filing, indicating a neutral impact and sentiment.

Enterprise value to revenue forward of Phibro Animal Health Corporation Class A – MUN:PB8

https://www.tradingview.com/symbols/MUN-PB8/financials-statistics-and-ratios/enterprise-value-sales-fwd/
This article provides financial metrics for Phibro Animal Health Corporation Class A (MUN:PB8) on the Munich Stock Exchange, specifically focusing on its enterprise value to revenue forward. It appears to be a financial data point from TradingView, offering a snapshot of the company's valuation.
Advertisement

Price to earnings forward of Phibro Animal Health Corporation Class A – MUN:PB8

https://www.tradingview.com/symbols/MUN-PB8/financials-statistics-and-ratios/price-earnings-fwd/
This article provides financial information for Phibro Animal Health Corporation Class A (MUN:PB8) on the Munich Stock Exchange, specifically focusing on its forward price-to-earnings ratio. It indicates that the market was closed at the time of publication with no trades. The content is primarily a data page from TradingView.

Price to sales forward of Phibro Animal Health Corporation Class A – MUN:PB8

https://www.tradingview.com/symbols/MUN-PB8/financials-statistics-and-ratios/price-sales-fwd/
This article displays the "Price to sales forward" value for Phibro Animal Health Corporation Class A under its Munich Stock Exchange ticker PB8. The financial data provided is limited, indicating that no specific trades or values are currently available. It appears to be a stub or a pre-filled page from TradingView.

New Phibro (NASDAQ: PAHC) CEO granted 300,000 performance-based RSUs

https://www.stocktitan.net/sec-filings/PAHC/8-k-phibro-animal-health-corp-reports-material-event-b176037d7a1c.html
Phibro Animal Health Corporation announced the appointment of Daniel (Dani) Bendheim as CEO and President, effective July 1, 2026. His compensation package includes an $850,000 annual base salary, a target 50% annual cash bonus, annual time-vesting RSUs, and an initial grant of 300,000 performance-based RSUs. These performance RSUs are set to vest by June 30, 2031, contingent on the company's 90-day average share price reaching between $70 and $100.

Price to book forward of Phibro Animal Health Corporation Class A – GETTEX:PB8

https://www.tradingview.com/symbols/GETTEX-PB8/financials-statistics-and-ratios/price-book-fwd/
The article provides a title for the "Price to book forward" metric for Phibro Animal Health Corporation Class A shares traded on GETTEX under the symbol PB8. It indicates that the market is currently closed with no trades. The content seems to be a template or header from a financial data platform like TradingView.

Phibro Animal Health Corporation Class A Actuals & Estimates (NASDAQ:PAHC)

https://www.tradingview.com/symbols/NASDAQ-PAHC/forecast-actuals-and-estimates/
This article provides an overview of Phibro Animal Health Corporation (NASDAQ:PAHC) stock, detailing its current price, market capitalization, and historical performance. It also includes analyst forecasts for future prices, upcoming earnings dates, and financial data such as revenue, net income, and dividend information, while clarifying that the content is not investment advice.
Advertisement

PHIBRO ANIMAL HEALTH CORP SEC Filing

https://www.stocktitan.net/sec-filings/PAHC/144-phibro-animal-health-corp-sec-filing-956e651437c4.html
Phibro Animal Health Corporation filed a Form 144 notice, disclosing proposed sales of 281,600 shares of Class A Common Stock. The filing details multiple smaller transactions by BFI Co. LLC, handled by Goldman Sachs & Co. LLC, which occurred between March and May 2026. These filings are procedural disclosures for resale activity under Rule 144.

Phibro Animal Health Up 10% After Insider Move

https://www.bez-kabli.pl/phibro-animal-health-up-10-after-insider-move/
Phibro Animal Health Corp shares rose over 10% following a director's purchase of Class A shares on the open market after a recent decline, despite ongoing investor concerns about Brazil's regulatory environment and the company's guidance. The company announced a quarterly cash dividend of 12 cents per share, and its latest quarterly net sales and adjusted EBITDA saw significant increases. However, recent analyst ratings have been cautious, with a consensus put at "Hold."

Phibro Animal Health director E. Thomas Corcoran buys $317,700 in stock

https://www.investing.com/news/insider-trading-news/phibro-animal-health-director-e-thomas-corcoran-buys-317700-in-stock-93CH-4723148
Phibro Animal Health Corp. director E. Thomas Corcoran purchased 10,000 shares of the company's Class A Common Stock for $317,700 on May 29, 2026, at a weighted average price of $31.77 per share. This transaction increased his direct holdings to 41,459 shares. The purchase occurred shortly after the company announced strong Q3 fiscal year 2026 results, exceeding analyst expectations for both EPS and revenue, despite a subsequent dip in the stock price.

Phibro Animal Health director E. Thomas Corcoran buys $317,700 in stock By Investing.com

https://m.za.investing.com/news/insider-trading-news/phibro-animal-health-director-e-thomas-corcoran-buys-317700-in-stock-93CH-4311335?ampMode=1
E. Thomas Corcoran, a director at Phibro Animal Health Corp. (NASDAQ:PAHC), recently purchased 10,000 shares of the company's Class A Common Stock for a total of $317,700. This transaction occurred on May 29, 2026, at an average price of $31.77 per share. Following this purchase, Corcoran now directly holds 41,459 shares, and the acquisition comes as the stock trades at $28.52, down 15% over the past week, following a negative market reaction to strong Q3 fiscal year 2026 financial results that exceeded analyst forecasts.

Phibro Animal Health (PAHC) director buys 10,000 shares in market

https://www.stocktitan.net/sec-filings/PAHC/form-4-phibro-animal-health-corp-insider-trading-activity-c8cc0491c306.html
E. Thomas Corcoran, a director at Phibro Animal Health (PAHC), purchased 10,000 shares of Class A Common Stock in an open-market transaction. The shares were bought at a weighted average price of $31.77 per share. Following this acquisition, Corcoran directly holds 41,459 shares, which includes shares obtained through a dividend reinvestment plan.
Advertisement
Advertisement
Advertisement
Advertisement

Sign Up free to view live trades and discussion forum to make more informed financial decisions. No credit card is required for sign up!
View Daily Trades
Join Discussion

Advertisement
Advertisement
Advertisement
Advertisement